Invictus MD Moves To TSX Venture Exchange
April 06 2017 - 9:30AM
InvestorsHub NewsWire
VANCOUVER, BC
-- April 6, 2017 -- InvestorsHub NewsWire -- INVICTUS MD STRATEGIES
CORP. (TSXV:IMH)(OTCPK:IVITF) ("Invictus MD" or
the "Company"), Canada’s cannabis company, is pleased to
announce that its common shares will be delisted from the
Canadian Securities Exchange after the close of trading on March
30, 2017 and will be listed on the TSX Venture Exchange
("TSXV") commencing at the open of trading on
March 31, 2017. There will be no interruption in trading and the
Company's trading symbol "IMH" will remain the same.
Invictus MD’s move
from the CSE to the TSXV follows a year of significant
achievements. We now have 250 acres of cultivation space
that stretches from Alberta to Ontario. Invictus MD’s option to now
acquire 100% of Acreage Pharms Ltd. in Alberta the site of our
Licensed Producer facility which has low cost of production as a
result of low energy and water costs. The property is friendly to
building as many square feet as required based on the significant
demand. The CEO of Acreage Pharms is a serial entrepreneur and has
been successful in previous ventures.
“As one of the few
cannabis producing companies in North America listed on a major
exchange such as the TSXV, this move will enable us to engage a
wider investor audience,” said Dan Kriznic, Chairman & CEO, Invictus MD.
“The TSXV is the stock exchange for many of Canada’s publicly
traded Licensed Producers, and we hope that the addition of
Invictus MD helps to continue to signal that the view of cannabis
has changed,” added Kriznic. “This is a significant day for our
Company, our sector and investors. We are strongly focused on
building our shareholder value, and will continue the disciplined
but agile execution of our business strategy to solidly expand our
position as Canada’s Cannabis Company.”
In
connection with the TSXV listing, the Company has made an
undertaking to the TSXV that no foreign operations will be
undertaken by Invictus or any of Invictus’ subsidiaries until the
approval of the TSXV for such operations is received. Invictus will
undertake to the TSXV that, for so long as any securities of
Invictus are listed on the TSXV, Invictus and its subsidiaries will
only conduct the business of the production, sale and distribution
of medicinal marijuana in Canada pursuant to one or more licenses
issued by Health Canada in accordance with applicable law, unless
prior approval is obtained from the TSXV.
About Invictus
MD Strategies Corp.
Invictus MD Strategies Corp. is focused on three main verticals
within the burgeoning Canadian cannabis sector: Licensed Producers
under the ACMPR including an investment in a fully licensed
facility, AB Laboratories Inc. as well as the option to now acquire
100% of Acreage Pharms Ltd.; Fertilizer and Nutrients through
Future Harvest Development Ltd.; and Cannabis Data and Delivery,
with its wholly owned subsidiary Poda Technologies Ltd.
For more
information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman &
CEO
Larry
Heinzlmeir
Vice President,
Marketing & Communications
604-537-8676
CAUTIONARY NOTE
REGARDING FORWARD-LOOKING STATEMENTS: This news release contains
certain "forward-looking statements" within the meaning of such
statements under applicable securities law. Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. There is no assurance that the Proposal
will be completed on the terms or within the timeframe contemplated
in this news release or at all. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither the TSX
Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (CE) (USOTC:IVITF)
Historical Stock Chart
From Sep 2023 to Sep 2024